Search Results 1491-1500 of 11393 for anti-TNF drugs
This designation recognizes the institution's scientific excellence and multidisciplinary resources focused on cancer prevention, diagnosis and treatment.
Targeted therapy for cancer is a treatment that uses medicines that attack specific chemicals in the cancer cells. By blocking these chemicals, targeted ...
Inclisiran, developed by The Medicines Company, is a siRNA (small interfering RNA) drug and the only cholesterol-lowering medication in its class. The ...
Additionally Ratio Therapeutics will learn if \[Ac225\]RTX-2358 drug is effective in treating advanced sarcoma. The main questions the study aims to answer in ...
... treatment for pre-menopausal women with ER+/HER2- breast cancer. (Z)-endoxifen belongs to a group of drugs called selective estrogen receptor modulators or ...
Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices. Medical records research — uses historical ...
Rushna P. Ali, M.D.. Neurosurgeon. Rochester, MN. Areas of focus: Deep brain stimulation, Computer assisted brain surgery, Ablation therapy, ...
Venetoclax is FDA approved for the treatment of CLL and SLL. The drug combination of acalabrutinib, durvalumab, and venetoclax is experimental and isn't ...
Drugs & Supplements · Healthy Lifestyle · Mayo ... drugs that contain the metal platinum but then ... anti-tumor activity. A Vaccine (H2NVAC) Before ...
If a subject is receiving an anti-PD-1 or anti-PD-L1 antibody on a shorter frequency; i.e., every two weeks, then the subject is eligible if last dose within 2 ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.